Legal Representation
Attorney
Ian W. Gillies
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 21, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 21, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 21, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 21, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 21, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 19, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 6, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 1, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 1, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic pharmaceutical preparations, microbe-targeted pharmaceutical preparations, or host-targeted pharmaceutical preparations for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, and gastrointestinal and immunological diseases; Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic pharmaceutical preparations, microbe-targeted pharmaceutical preparations, or host-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science
Class 005
Probiotic pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases; Microbe-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases; Host-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases; Chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, and gastrointestinal and immunological diseases
Class 042
Providing medical research and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic pharmaceutical products, microbe-targeted pharmaceutical products, or host-targeted pharmaceutical products; research in the fields of conducting clinical trials for others, biochemistry, and biotechnology
Class 044
Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic, microbe-targeted, or host-targeted pharmaceuticals
Classification
International Classes
001
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"